Amgen reports positive trial results for high-cholesterol treatment
The portion of Amgen’s Phase 3 trial of evolocumab that evaluated patients with high cholesterol who cannot tolerate statins has met goals related to percent reduction of low-density lipoprotein cholesterol.
Read More →Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Read More →SBA responds to statewide drought with disaster loans
In response to economic losses caused by the statewide drought, certain small businesses across California, including in the Tri-Counties, are now eligible to apply for low-interest federal loans from the U.S. Small Business Administration, the agency announced on Jan. 21. Small, non-farm businesses, small agricultural cooperatives, small businesses engaged in aquaculture, and most private, nonprofit Read More →
Read More →Cruise ship industry floats $2.4M into Santa Barbara
The cruise ship industry had an estimated $2.4 million economic impact on Santa Barbara last year, with more than 50,000 passengers visiting the city, according to a recently released survey.
Read More →Lynda.com hires execs for international push
Carpinteria-based online education firm lynda.com has added four executives to bolster its international growth efforts.
Read More →Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Read More →
Sponsored content:
2015-2016 Giving Guide
